BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 34038739)

  • 1. Temperate phage-antibiotic synergy eradicates bacteria through depletion of lysogens.
    Al-Anany AM; Fatima R; Hynes AP
    Cell Rep; 2021 May; 35(8):109172. PubMed ID: 34038739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny.
    Al-Anany AM; Fatima R; Nair G; Mayol JT; Hynes AP
    mBio; 2024 Jun; 15(6):e0050424. PubMed ID: 38757974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage tRNA-dependent lysogeny: requirement of phage-encoded tRNA genes for establishment of lysogeny.
    Guerrero-Bustamante CA; Hatfull GF
    mBio; 2024 Feb; 15(2):e0326023. PubMed ID: 38236026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophages benefit from generalized transduction.
    Fillol-Salom A; Alsaadi A; Sousa JAM; Zhong L; Foster KR; Rocha EPC; Penadés JR; Ingmer H; Haaber J
    PLoS Pathog; 2019 Jul; 15(7):e1007888. PubMed ID: 31276485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental structure drives resistance to phages and antibiotics during phage therapy and to invading lysogens during colonisation.
    Sousa JAM; Rocha EPC
    Sci Rep; 2019 Feb; 9(1):3149. PubMed ID: 30816246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage-antibiotic synergy: Cell filamentation is a key driver of successful phage predation.
    Bulssico J; PapukashvilI I; Espinosa L; Gandon S; Ansaldi M
    PLoS Pathog; 2023 Sep; 19(9):e1011602. PubMed ID: 37703280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of temperate phages drives loss of type I CRISPR-Cas systems.
    Rollie C; Chevallereau A; Watson BNJ; Chyou TY; Fradet O; McLeod I; Fineran PC; Brown CM; Gandon S; Westra ER
    Nature; 2020 Feb; 578(7793):149-153. PubMed ID: 31969710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage-Antibiotic Synergy Inhibited by Temperate and Chronic Virus Competition.
    Landa KJ; Mossman LM; Whitaker RJ; Rapti Z; Clifton SM
    Bull Math Biol; 2022 Mar; 84(5):54. PubMed ID: 35316421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophages in Lactobacillus reuteri Are Associated with Fitness Trade-Offs but Can Increase Competitiveness in the Gut Ecosystem.
    Oh JH; Lin XB; Zhang S; Tollenaar SL; Özçam M; Dunphy C; Walter J; van Pijkeren JP
    Appl Environ Microbiol; 2019 Dec; 86(1):. PubMed ID: 31676478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in phage induction enables the survival of the lysogenic population.
    Imamovic L; Ballesté E; Martínez-Castillo A; García-Aljaro C; Muniesa M
    Environ Microbiol; 2016 Mar; 18(3):957-69. PubMed ID: 26626855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple solid media assay for detection of synergy between bacteriophages and antibiotics.
    Khong E; Oh JJ; Jimenez JM; Liu R; Dunham S; Monsibais A; Rhoads A; Ghatbale P; Garcia A; Cobián Güemes AG; Blanc AN; Chiu M; Kuo P; Proost M; Kline A; Aslam S; Schooley RT; Whiteson K; Fraley SI; Pride DT
    Microbiol Spectr; 2024 May; 12(5):e0322123. PubMed ID: 38526142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Basis of Lysis-Lysogeny Decisions in Gram-Positive Phages.
    Brady A; Felipe-Ruiz A; Gallego Del Sol F; Marina A; Quiles-Puchalt N; Penadés JR
    Annu Rev Microbiol; 2021 Oct; 75():563-581. PubMed ID: 34343015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Dynamics of Phage and Bacteria in Spatially Structured Habitats Using Phage λ and Escherichia coli.
    Mitarai N; Brown S; Sneppen K
    J Bacteriol; 2016 Jun; 198(12):1783-93. PubMed ID: 27068593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What makes a temperate phage an effective bacterial weapon?
    Thomas MJN; Brockhurst MA; Coyte KZ
    mSystems; 2024 Jun; 9(6):e0103623. PubMed ID: 38727217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stumbling across the Same Phage: Comparative Genomics of Widespread Temperate Phages Infecting the Fish Pathogen Vibrio anguillarum.
    Kalatzis PG; Rørbo NI; Castillo D; Mauritzen JJ; Jørgensen J; Kokkari C; Zhang F; Katharios P; Middelboe M
    Viruses; 2017 May; 9(5):. PubMed ID: 28531104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.
    Shariati A; Noei M; Chegini Z
    J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth.
    Comeau AM; Tétart F; Trojet SN; Prère MF; Krisch HM
    PLoS One; 2007 Aug; 2(8):e799. PubMed ID: 17726529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Interactions among
    Lauman P; Dennis JJ
    Microbiol Spectr; 2023 Jun; 11(3):e0443022. PubMed ID: 37195168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.